Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Systech International Adds Distinguished Members to its Board

Published: Tuesday, February 12, 2013
Last Updated: Tuesday, February 12, 2013
Bookmark and Share
Systech International announces the addition of John Bailye and Michael Fawkes to its Board of Directors.

Robert DeJean, President and CEO, Systech International said: “We are delighted to welcome new members to our Board, John Bailye and Michael Fawkes, who bring a vast amount of industry experience and business acumen upon which Systech will draw as we continue to grow.”

John Bailye is a globally accomplished entrepreneur with a resume that runs the gamut from start-ups to proven operational management and strategic leadership in mid to large sized companies. John’s successes reflect a passion for focusing on his customers, both as a source of product direction and, as the ultimate arbiter of his companies’ success.

In a career covering strategic consulting services; leading edge global technology development and deployment and; of late, specialty pharmaceuticals, he has consistently demonstrated his ability to build great management teams and deliver outstanding returns to shareholders. In John’s penultimate role, he guided, developed and grew Dendrite International from a two-person startup company to a complex global business entity over a period of 20 years. Dendrite had $750 million in market capitalized value, over $450 million in annual sales with high profitability, and more than 3000 employees in over 25 countries.

John Bailye said: “I am honored to join Systech’s Board of Directors. As a market leader with innovative technology in a rapidly growing market and new senior management additions, Systech is poised for significant growth. The company is thriving and I’m eager to help shape the organizational direction over the coming months and years.”

Michael Fawkes brings more than 30 years of experience to the Systech Board. Currently he serves as an Independent Director for Saba Software, a NASDAQ listed company, as well as several private technology companies.

From February 2008 through January 2012, Michael served as an Operating Partner with Vantage Point Capital Partners, a leading global investor in energy innovation and efficiency, information technology and healthcare.

Prior to joining Vantage Point Capital Partners, Michael spent 29 years at Hewlett-Packard Company, a leading global provider of products, technologies, software, solutions and services to individuals and businesses, serving in various executive roles in operations and finance, including Senior Vice President of Operations for HP’s Imaging and Printing business. Prior to joining HP, Michael was a CPA with Arthur Andersen. Michael holds a B.B.A. and a M.A. in Finance from the University of Iowa.

Michael Fawkes said: “Systech is positioned very well to make a critical contribution to patient safety as it helps its customers combat counterfeiting in the Pharmaceutical market. Additionally, Systech has a tremendous opportunity to advance its offering to other markets. I am thrilled to have the opportunity to work with Systech as its scales for the future.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Key to Natural Detoxifier’s Reactivity Discovered
Results have implications for health, drug design and chemical synthesis.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos